Citations

Clear

6263 citation(s) found for "Ip, Andrew".

Continuous association of cadherin with β-catenin requires the non-receptor tyrosine-kinase Fer
Xu, Gang , Craig, Andrew W. , Greer, Peter A. , Miller, Matthew J. , Anastasiadis, Panos Z. , Lilien, Jack, Balsamo, Janne

Mayo Clinic

Journal of Cell Science | June 28, 2004 | Volume: 117 | Issue: 15 | Pages: 3207-3219

10.1242/jcs.01174 | PMID 15226396 Get It

The function of Type 1, classic cadherins depends on their association with the actin cytoskeleton, a connection mediated by α- and β-catenin. The phosphorylation state of β-catenin is crucial for its association with cadherin and thus the association of cadherin with the cytoskeleton. We now show that the phosphorylation of β-catenin is regulated by the combined activities of the tyrosine kinase Fer and the tyrosine phosphatase PTP1B. Fer phosphorylates PTP1B at tyrosine 152, regulating its binding to cadherin and the continuous dephosphorylation of β-catenin at tyrosine 654. Fer interacts with cadherin indirectly, through p120ctn. We have mapped the interaction domains of Fer and p120ctn and peptides corresponding to these sequences release Fer from p120ctn in vitro and in live cells, resulting in loss of cadherin-associated PTP1B, an increase in the pool of tyrosine phosphorylated β-catenin and loss of cadherin adhesion function. The effect of the peptides is lost when a β-catenin mutant with a substitution at tyrosine 654 is introduced into cells. Thus, Fer phosphorylates PTP1B at tyrosine 152 enabling it to bind to the cytoplasmic domain of cadherin, where it maintains β-catenin in a dephosphorylated state. Cultured fibroblasts from mouse embryos targeted with a kinase-inactivating ferD743R mutation have lost cadherin-associated PTP1B and β-catenin, as well as localization of cadherin and β-catenin in areas of cell-cell contacts. Expression of wild-type Fer or culture in epidermal growth factor restores the cadherin complex and localization at cell-cell contacts.
MULTIPLE CALCIUM PHOSPHATE STONES OCCUPYING A CALICEAL DIVERTICULUM
Krambeck, Amy E. , LeRoy, Andrew J., Fisher, Dirk T., Segura, Joseph W.

Mayo Clinic

Journal of Urology | June 2, 2004 | Volume: 172 | Issue: 1 | Pages: 164-165

10.1097/01.ju.0000129003.74499.2c | PMID 15201762 Get It

OBSERVATIONS ON ORGANIZATION OF Z-DISK COMPONENTS AND ON ROD-BODIES OF Z-DISK ORIGIN
Macdonald, Ronald D., Engel, Andrew G.

Mayo Clinic

The Journal of Cell Biology | May 14, 2004 | Volume: 48 | Issue: 2 | Pages: 431-437

10.1083/jcb.48.2.431 | PMID 4928022 Get It

Differential Effects of Interleukin-7 and Interleukin-15 on NK Cell Anti-Human Immunodeficiency Virus Activity
Schnepple, David, Nie, Zilin , Sanchez-Dardon, Jaime, Mbisa, Georgina, Mihowich, Jennifer, Hawley, Nanci, Narayan, Shanil, Kim, John E., Badley, Andrew D. , Lum, Julian J. , Lynch, David H. , Badley, Andrew D

Mayo Clinic

Journal of Virology | May 12, 2004 | Volume: 78 | Issue: 11 | Pages: 6033-6042

10.1128/jvi.78.11.6033-6042.2004 | PMID 15141001 Get It

ABSTRACTThe ability of interleukin-7 (IL-7) and IL-15 to expand and/or augment effector cell functions may be of therapeutic benefit to human immunodeficiency virus (HIV)-infected patients. The functional effects of these cytokines on innate HIV-specific immunity and their impact on cells harboring HIV are unknown. We demonstrate that both IL-7 and IL-15 augment natural killer (NK) function by using cells (CD3−CD16+CD56+) from both HIV-positive and -negative donors. Whereas IL-7 enhances NK function through upregulation of Fas ligand, the effect of IL-15 is mediated through upregulation of tumor necrosis factor-related apoptosis-inducing ligand. The difference in these effector mechanisms is reflected by the ability of IL-15-treated but not IL-7-treated NK cells to reduce the burden of replication-competent HIV in autologous peripheral blood mononuclear cells (PBMC) (infectious units per million for control NK cells, 6.79; for IL-7-treated NK cells, 236.17; for IL-15-treated cells, 1.01;P= 0.01 versus control). In addition, the treatment of PBMC with IL-15-treated but not IL-7-treated NK cells causes undetectable HIV p24 (five of five cases), HIV RNA (five of five cases), or HIV DNA (three of five cases). These results support the concept of adjuvant immunotherapy of HIV infection with either IL-7 or IL-15 but suggest that the NK-mediated antiviral effect of IL-15 may be superior.
Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study
Gordon, Leo I. , Molina, Arturo , Emmanouilides, Christos, Raubtischek, Andrew, Darif, Mohamed, Schilder, Russell J., Wiseman, G. , White, Christine A., Witzig, Thomas E. , Gordon, Leo I

Mayo Clinic

Blood | March 16, 2004 | Volume: 103 | Issue: 12 | Pages: 4429-4431

10.1182/blood-2003-11-3883 | PMID 15016644 Get It

Abstract We previously demonstrated that yttrium-90 (Y-90) ibritumomab tiuxetan (Zevalin) radioimmunotherapy (RIT) was safe and effective for relapsed or refractory CD20+, B-cell, non-Hodgkin lymphoma (NHL). We now provide long-term follow-up data in responding patients based on International Workshop Response Criteria. Complete (CR), CR unconfirmed (CRu), and partial response (PR) rates were 29%, 22%, and 22%, respectively (overall response rate 73%, 51% in CR/CRu). Mean time to progression (TTP) and duration of response (DR) in responders were 12.6 months and 11.7 months, respectively. At the maximum tolerated dose (0.4 mCi/kg [14.8 MBq/kg]), TTP and DR in complete responders (CR/CRu) were 28.3 and 27.5 months, respectively. Nine patients (24% of responding patients) had a TTP of more than 3 years. Long-term responders (> 5 years) have been identified. Ibritumomab tiuxetan produces durable responses in patients with indolent and diffuse large B-cell lymphoma. (Blood. 2004;103:4429-4431)
Pulmonary Hemangiomas of Infancy and Childhood: Report of Two Cases and Review of the Literature
Abrahams, Neil A., Colby, Thomas V. , Pearl, Richard H., Chipps, Bradley E. , Juris, Andrew L., Leslie, Kevin O.

Mayo Clinic

Pediatric and Developmental Pathology | December 2, 2003 | Volume: 5 | Issue: 3 | Pages: 283-292

10.1007/s10024-001-0151-x | PMID 12007021 Get It

Pulmonary hemangiomas are exceptionally rare in childhood and more so in infancy. They may involve the airways or the parenchyma, and may be localized or multifocal. We present two cases of pulmonary capillary hemangiomas. The first case is a localized form of capillary hemangioma that was resected from an 8-week-old infant with signs of respiratory distress. A computed tomography scan showed a cystic mass initially thought to be an intrapulmonary bronchogenic cyst. A segmental resection was performed and examination revealed a localized capillary hemangioma without cystic or cavernous features. The second case is an example of a multifocal capillary hemangioma from a 9-year-old child who presented clinically with clubbing of fingers and toes and radiologically had multiple discrete nodules localized to the right lung. The clinical and pathological features of the cases are discussed together with a review of the literature. The distinction from other vascular neoplasms of childhood is briefly described. Although rare, pulmonary hemangiomas should be entertained in the diagnosis of both solid and cystic intrapulmonary lesions of childhood and infancy.
Lung Epithelial Cells and Extracellular Matrix Components Induce Expression of Pneumocystis carinii STE20 , a Gene Complementing the Mating and Pseudohyphal Growth Defects of ste20 Mutant Yeast
Köhler, Julia R. , Thomas, Charles F., Fink, Gerald R. , Kottom, Theodore J. , Limper, Andrew H.

Mayo Clinic

Infection and Immunity | October 24, 2003 | Volume: 71 | Issue: 11 | Pages: 6463-6471

10.1128/iai.71.11.6463-6471.2003 | PMID 14573668 Get It

ABSTRACT Pneumocystis carinii causes severe pneumonia in immunocompromised hosts. The binding of P. carinii to alveolar epithelial cells and extracellular matrix constituents such as fibronectin and vitronectin is a central feature of infection, which initiates proliferation of the organism. Herein, we demonstrate that P. carinii binding to lung cells specifically alters the gene expression of the organism, regulating fungal growth. Subtractive hybridization was performed to isolate P. carinii genes expressed following binding to mammalian extracellular matrix constituents. P. carinii STE20 ( PCSTE20 ), a gene participating in mating and pseudohyphal growth of other fungi, was identified following adherence to the extracellular matrix constituents fibronectin, vitronectin, collagen, and lung epithelial cells. The expression of PCSTE20 and a related P. carinii mitogen-activated protein kinase (MAPK) kinase gene, also implicated in signaling of mating, were both specifically upregulated by binding to matrix protein. The expression of general cyclin-dependent kinases and other MAPKs not involved in mating pathways were not altered by organism binding. PCSTE20 expression was also strongly enhanced following organism attachment to A549 lung epithelial cells. When expressed in a Saccharomyces cerevisiae ste20Δ mutant, PCSTE20 suppressed defects in both mating and pseudohyphal growth. These findings are consistent with the observed proliferation and filopodial extension of Pneumocystis organisms adherent to the epithelium in the lungs of immunocompromised hosts. PCSTE20 expression appears to represent a significant component in the regulation of the life cycle of this intractable opportunistic pathogen.
Evidence for a Melanin Cell Wall Component in Pneumocystis carinii
Icenhour, Crystal R., Kottom, Theodore J. , Limper, Andrew H.

Mayo Clinic

Infection and Immunity | August 21, 2003 | Volume: 71 | Issue: 9 | Pages: 5360-5363

10.1128/iai.71.9.5360-5363.2003 | PMID 12933884 Get It

ABSTRACT Fluorescein isothiocyanate-labeled monoclonal antibodies specific for fungal melanin were used in this study to visualize melanin-like components of the Pneumocystis carinii cell wall. A colorimetric enzyme assay confirmed these findings. This is the first report of melanin-like pigments in Pneumocystis .
Predicting Endothelial Cell Loss and Long-Term Corneal Graft Survival
Armitage, W. John, Dick, Andrew D. , Bourne, William M., Armitage, W. John

Mayo Clinic

Investigative Opthalmology & Visual Science | July 25, 2003 | Volume: 44 | Issue: 8 | Pages: 3326

10.1167/iovs.02-1255 | PMID 12882777 Get It